--- title: "Chemical pharmaceutical concept experiences partial fluctuations, Xiao Fang Pharmaceutical and SL PHARM hit the limit up" type: "News" locale: "en" url: "https://longbridge.com/en/news/223041601.md" description: "The chemical pharmaceutical concept experienced partial fluctuations, with Xiao Fang Pharmaceutical and SL PHARM hitting the daily limit, Hendi Pharmaceutical rising over 10%, and LuKang Pharmaceutical, TuoXin Pharmaceutical, and New Hope Liuhe following suit" datetime: "2024-12-23T02:25:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/223041601.md) - [en](https://longbridge.com/en/news/223041601.md) - [zh-HK](https://longbridge.com/zh-HK/news/223041601.md) --- # Chemical pharmaceutical concept experiences partial fluctuations, Xiao Fang Pharmaceutical and SL PHARM hit the limit up The chemical pharmaceutical concept has seen partial fluctuations, with Xiao Fang Pharmaceutical and SL PHARM hitting the limit up, Hendi Pharmaceutical rising over 10%, and LuKang Pharmaceutical, TuoXin Pharmaceutical, and New Hope Liuhe following suit ### Related Stocks - [603207.CN](https://longbridge.com/en/quote/603207.CN.md) - [002038.CN](https://longbridge.com/en/quote/002038.CN.md) - [600789.CN](https://longbridge.com/en/quote/600789.CN.md) - [301089.CN](https://longbridge.com/en/quote/301089.CN.md) - [002001.CN](https://longbridge.com/en/quote/002001.CN.md) - [301211.CN](https://longbridge.com/en/quote/301211.CN.md) ## Related News & Research - [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md) - [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md) - [Trump signs order aimed at preventing illicit financial activity, White House says](https://longbridge.com/en/news/286970478.md) - [12:45 ETInventHelp Inventor Develops New Bandage Dispenser (TLS-1305)](https://longbridge.com/en/news/286946419.md) - [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)